Search Result "programmed death-ligand 1"
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 2 Year: 2016 Page: 141-151
Author(s): Xiao-Na Fang,Li-Wu Fu
The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 893-909
Author(s): Lifang Zhang,Yu Zhao,Quanmei Tu,Xiangyang Xue,Xueqiong Zhu,Kong-Nan Zhao
Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms
Journal: Current Drug Targets
Volume: 21 Issue: 13 Year: 2020 Page: 1286-1292
Author(s): Francesca Giunchi,Thomas Gevaert,Marina Scarpelli,Michelangelo Fiorentino
Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 896-905
Author(s): Fatma El-Gebaly,Sabry Abou-saif,Mahmoud Elkadeem,Amal Helmy,Sherief Abd-Elsalam,Mohamed Yousef,Reham Abdelkader Elkhouly,Ibrahim Fathi Amer,Taher El-Demerdash
Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: ImmunePharmacological Targets for Management of Breast Adenocarcinoma
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 13 Year: 2023 Page: 1571-1585
Author(s): Payel Ghosh Chowdhury,Pallab Kanti Haldar,Ashok Kumar Balaraman
Therapeutic Potential of Targeting Transforming Growth Factor-beta(TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer
Journal: Current Drug Targets
Volume: 24 Issue: 17 Year: 2023 Page: 1335-1345
Author(s):
Relationship with Programmed Cell Death Ligand 1 (PD-L1) and DTI Features in Brain Metastases of Non-small Cell Lung Cancer: A Preliminary Study
Journal: Current Medical Imaging
Volume: 17 Issue: 11 Year: 2021 Page: 1369-1373
Author(s): Temel Fatih Yilmaz,Ismail Yurtsever,Hacı Mehmet Turk,Mehmet Ali Gultekin,Mehmet Besiroglu,Dilek Hacer Cesme,Abdallah T M Shbair,Alpay Alkan
Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells
Journal: Current Signal Transduction Therapy
Volume: 10 Issue: 1 Year: 2015 Page: 63-72
Author(s): Kun Xu,Yan Zhang,Si-dong Wei,Pei-zhi Li,Kun He,Jian-ping Gong,Chun Huang
Cancer Immunotherapy: An Overview of Small Molecules as Inhibitors ofthe Immune Checkpoint PD-1/PD-L1 (2015-2021)
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 14 Year: 2022 Page: 1816-1827
Author(s): Federico Da Settimo
Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 5 Year: 2003 Page: 334-342
Author(s): Patrizia Marini, Claus Belka